APULI MARICEL (Chief Accounting Officer) sold 1.5% of their position (2K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $160.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/3/2026ACC: 0001470831-26-000745
Officer· Chief Accounting Officer
Since Feb 2026
-2K
Net shares
Net seller
$160.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2K
Price / share
$80.06
Trade value
$160.12K
% of position
1.5%
7/30/2026
129.40K→127.40K
Total
Net shares
−2K
Net value
-$160.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/30/2026 | S · Sale | −2K | $80.06 | $160.12K | 1.5% | 129.40K | 127.40K |
| Total | −2K | -$160.12K | ||||||
Derivative Transactions0
No derivative transactions reported